Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Feb 2026 for Phio Pharmaceuticals Corp..
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Curtis Lockshin: trading record in brief
Curtis Lockshin (board member) discloses dealings in Phio Pharmaceuticals Corp. to SEC (Form 4). We count 10 filings; the first trade dates from 29 August 2013 and the latest from 5 February 2026.
Every open-market trade on record is a purchase: 1 purchase worth €2,795, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 9 share grants.
Most recently, on 6 February 2026, the filings show a share grant in Phio Pharmaceuticals Corp. The most recent open-market purchase was published on 30 August 2013, 4,802 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Curtis Lockshin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
16,600 shares0Common Stock, $.0001 par valueSEC:0001683168-26-000813:0
16,200 shares0Common Stock, $.0001 par valueSEC:0001683168-25-006959:0
2,000 shares0Common Stock, $0.0001 par valueSEC:0001683168-24-006336:0
1,500 shares0Common stock, $0.0001 par valueSEC:0001209191-23-011942:0
10,000 shares0Common stock, $0.0001 par valueSEC:0001209191-22-010405:0
5 of 5 declarations
